Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Expects To Conduct 325,000 Adverse Drug Event Reviews In 2000

Executive Summary

FDA expects to conduct 325,000 adverse drug reaction report reviews in fiscal year 2000, according to estimates included in the agency's budget justification submitted to the House and Senate Appropriations Committees.

You may also be interested in...

PQRI Research May Loosen "Conservative" Product Quality Regs - FDA

Research stemming from the Product Quality Research Institute may help to loosen FDA's "conservative" product quality guidances and requirements, FDA staff told the American Association of Pharmaceutical Scientists annual meeting Nov. 15 in New Orleans.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts